MedTrace Logo

Clinical Outcomes After Implantation of a Monofocal Hydrophobic IOL, Bi-Flex 877PAY With POB-MA Preloaded Injector

NCT06469541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-06-21

No results posted yet for this study

Summary

The purpose of our investigation is to retrospectively assess visual outcomes, refractive stability, safety features of the lens and the incidence of developing PCO (posterior capsular opacification) in a 12-month period following mono- or bilateral implantation of the hydrophobic acrylic monofocal IOL, Bi-Flex 877PAY (Medicontur).

Conditions

  • Cataract

Sponsors & Collaborators

  • Medicontur Medical Engineering Ltd

    lead INDUSTRY

Principal Investigators

  • Sathish Srinivasan, Prof. · NHS Ayrshire and Arran

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-11
Primary Completion
2023-07-31
Completion
2023-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06469541 on ClinicalTrials.gov